Nanoparticle (NP)-based therapeutics have ushered in a new era in translational medicine.
However, despite the clinical success of NP technology, it is not well-understood how NPs …

The blood–brain barrier (BBB) has a significant contribution to homeostasis and protection
of the CNS. However, it also limits the crossing of therapeutics and thereby complicates the …

Infectious diseases of bacterial and viral origins contribute to substantial mortality worldwide.
Collaborative efforts have been underway between academia and the industry to develop …

Nanoparticles (NPs) have been widely used for immobilization of wide ranges of enzymes.
However, the stabilization of enzymes on NPs is a major challenge, crucial for regulating …

Background Nanomaterials are being explored in the food and agricultural industries for
their potential applications in improving the safety, quality, health, and sustainability of the …

Lipid nanoparticles (LNPs) have successfully entered the clinic for the delivery of mRNA-and
siRNA-based therapeutics, most recently as vaccines for COVID-19. Nevertheless, there is a …

Abstract Nowadays, nano-/micro-motors are considered as powerful tools in different areas
ranging from cleaning all types of contaminants, to development of Targeted drug delivery …

The application of lipid-based nanoparticle (LNP) delivery systems remains a popular
strategy for the systemic delivery of gene therapies to specific disease targets, including …

Several studies have been conducted to address the potential adverse health risks
attributed to exposure to nanoscale materials. While in vivo studies are fundamental for …

Nanoparticles (NPs) in contact with biological fluids form a biomolecular corona through
interactions with proteins, lipids, and sugars, acquiring new physicochemical properties …